CANCER-PHOBIA - OR WHATEVER HAPPENED TO RED M+MS

被引：6

作者：

BALLENTINE, R ^{[1
]}

机构：

[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,HOUSTON,TX 77030

来源：

DRUG INTELLIGENCE & CLINICAL PHARMACY | 1982年 / 16卷 / 01期

关键词：

D O I：

10.1177/106002808201600109

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：60 / 61

页数：2

共 9 条

[1]

CRUDI CB, 1980, 4 NATL THER ASS, V3, P77

[2]

DAVIS MR, 1981, HOSP PHARM, V16, P17

[3]

FALCK K, 1979, LANCET, V1, P1250

[4]

HOFFMAN D M, 1980, Hospital Pharmacy, V15, P302

[5] HANDLING OF INJECTABLE ANTI-NEOPLASTIC AGENTS [J].

KNOWLES, RS ;

VIRDEN, JE .

[6] PRECAUTIONARY MEASURES IN THE PREPARATION OF ANTINEOPLASTICS [J].

LADIK, CF ;

STOEHR, GP ;

MAURER, MA .

AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1980, 37 (09) :1184-&

[7]

STAIANO N, 1981, LANCET, V1, P615

[8]

TORTORICI M P, 1980, Hospital Pharmacy, V15, P295

[9] ANTINEOPLASTICS - A SAFETY HAZARD [J].

WILSON, JP ;

SOLIMANDO, DA .

AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1981, 38 (05) :624-624